Edition:
United Kingdom

Revance Therapeutics Inc (RVNC.OQ)

RVNC.OQ on NASDAQ Stock Exchange Global Market

30.85USD
18 May 2018
Change (% chg)

$0.05 (+0.16%)
Prev Close
$30.80
Open
$30.70
Day's High
$31.65
Day's Low
$30.70
Volume
57,830
Avg. Vol
83,875
52-wk High
$37.45
52-wk Low
$18.80

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.93 December 21 May 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 9 9 8 7
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 9 0.40 2.00 0.00 0.09
Quarter Ending Sep-18 9 0.51 3.00 0.00 0.09
Year Ending Dec-18 10 1.60 10.19 0.00 0.35
Year Ending Dec-19 9 2.61 15.41 0.00 22.84
Earnings (per share)
Quarter Ending Jun-18 8 -0.93 -0.81 -0.99 -0.81
Quarter Ending Sep-18 8 -0.94 -0.81 -1.04 -0.78
Year Ending Dec-18 9 -3.71 -3.25 -4.06 -3.43
Year Ending Dec-19 8 -3.88 -2.97 -4.32 -3.53

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 5.07 0.19 4.87 96.19
Quarter Ending Dec-17 0.08 0.04 0.04 50.67
Quarter Ending Sep-17 0.05 0.08 0.03 50.00
Quarter Ending Jun-17 0.05 0.08 0.03 50.00
Quarter Ending Mar-17 0.06 0.08 0.01 20.00
Earnings (per share)
Quarter Ending Mar-18 -0.71 -0.97 0.26 -36.20
Quarter Ending Dec-17 -0.97 -1.14 0.17 -17.18
Quarter Ending Sep-17 -0.93 -1.01 0.08 -8.14
Quarter Ending Jun-17 -0.94 -0.90 0.04 -4.66
Quarter Ending Mar-17 -0.85 -0.94 0.09 -10.59

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.40 0.36 0.11 0.11 0.09
Quarter Ending Sep-18 0.51 0.46 0.11 0.11 0.09
Year Ending Dec-18 1.60 1.60 5.42 5.99 0.35
Year Ending Dec-19 2.61 2.61 0.53 0.56 22.84
Earnings (per share)
Quarter Ending Jun-18 -0.93 -0.93 -0.90 -0.89 -0.81
Quarter Ending Sep-18 -0.94 -0.94 -0.92 -0.91 -0.78
Year Ending Dec-18 -3.71 -3.71 -3.47 -3.43 -3.43
Year Ending Dec-19 -3.88 -3.88 -3.82 -3.84 -3.53

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 2 1
Quarter Ending Sep-18 0 0 2 1
Year Ending Dec-18 0 0 0 3
Year Ending Dec-19 0 0 2 0
Earnings
Quarter Ending Jun-18 0 0 1 4
Quarter Ending Sep-18 0 0 2 3
Year Ending Dec-18 0 0 1 5
Year Ending Dec-19 0 0 2 4